Amanote Research
Register
Sign In
RILP Suppresses Invasion of Breast Cancer Cells by Modulating the Activity of RalA Through Interaction With RalGDS
Cell Death and Disease
- United Kingdom
doi 10.1038/cddis.2015.266
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Date
October 1, 2015
Authors
Z Wang
Y Zhou
X Hu
W Chen
X Lin
L Sun
X Xu
W Hong
T Wang
Publisher
Springer Science and Business Media LLC
Related search
Golgi Tethering Factor Golgin-97 Suppresses Breast Cancer Cell Invasiveness by Modulating NF-κB Activity
Cell Communication and Signaling
Biochemistry
Cell Biology
Molecular Biology
Novel Aryl Hydrocarbon Receptor Agonist Suppresses Migration and Invasion of Breast Cancer Cells
PLoS ONE
Multidisciplinary
MicroRNA‑124 Suppresses Cell Proliferation and Invasion of Triple Negative Breast Cancer Cells by Targeting STAT3
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
ADAMTS1-mediated Targeting of TSP-1 by PPARδ Suppresses Migration and Invasion of Breast Cancer Cells
Oncotarget
Oncology
Knockdown of ARK5 Expression Suppresses Invasion of Ovarian Cancer Cells
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
Keumsa Linteusan Suppresses Invasion of Cancer Cells Through the Inhibition of Cellular Adhesion and MMP‐9 Expression
Animal Cells and Systems
Animal Science
Zoology
Genetics
Molecular Biology
Biochemistry
Correction: MicroRNA-130b Suppresses Migration and Invasion of Colorectal Cancer Cells Through Downregulation of Integrin Β1
PLoS ONE
Multidisciplinary
Celastrol Suppresses Invasion of Colon and Pancreatic Cancer Cells Through the Downregulation of Expression of CXCR4 Chemokine Receptor
Journal of Molecular Medicine
Molecular Medicine
Drug Discovery
Genetics
Zerumbone Suppresses EGF-induced CD44 Expression Through the Inhibition of STAT3 in Breast Cancer Cells
Oncology Reports
Medicine
Cancer Research
Oncology